| Personlige Data | | 
|
| Navn: | Anders Poulsen |
| Adresse: | 42 Pasir Panjang Hill |
| | #03-11 Le Hill Condo |
| | Singapore 118894 |
| Tlf.: | +65 6777 1926 |
| E-Mail: | |
| Hjemmeside | www.colours.dk/anders |
| Alder: | 35 år, født d.3. maj 1972 |
| Status: | Gift med Violeta Magat |
| | |
| Erhvervserfaring | |
| Okt. 03- | Ansat iS*BIO Pte Ltd |
| DD. | Jeg arbejder som erhvervsforsker indenfor computational medicinal kemi. Jeg er ansat som Senior Scientist & Lab Head |
| Okt. 99- | Ansat iH.Lundbeck A/S |
| Sep. 03 | Jeg arbejdede som erhvervsforsker studerende og senere som erhvervsforsker indenfor computational medicinal kemi. |
| | |
| Uddannelse | |
| Jan. 00- | Danmarks Farmaceutiske Højskole (DFH) / H. Lundbeck A/S |
| Feb. 03 | Erhvervsforsker og Ph. D. i Medicinal Kemi / Computational Chemistry |
| | Ph.D. Afhandling: Pharmacophore and Receptor Models for Neurokinin Receptors |
| Feb. 93- | DanmarksTekniske Universitet (DTU) |
| Mar. 98 | Civilingeniør, kemiingeniør |
| | Midtvejsprojekt: Resolveringog derivatisering af 6-Nitroindan-1-carboxylsyre i samarbejde med H.Lundbeck A/S. |
| | Forprojekt:Syntese og karakterisation af deaktiveringsprodukter af den vanadiumbaseredeSO2-oxidationskatalysator fra HaldorTopsøe A/S. |
| | Afgangsprojekt:Syntese af azaheterocykler via ringslutningsmetathese. |
| |
| Sprog | Flydende engelsk i såvelskrift som tale. Taler tysk samt noget fransk og malay. |
| | |
| Patenter | WO-03051869 (Udstedt) |
| | "3,4-dihydro-1H-isoquinolin-2-yl-derivatives" |
| | WO-05016884 (Udstedt) |
| | "Cyclopropyl derivatives as NK3 receptor antagonists" |
| | WO-07058628A1 (PCT ansøgning) |
| | "Heteroalkyl linked pyrimidine derivatives" |
| | WO-07058627A1 (PCT ansøgning) |
| | "Oxygen linked pyrimidine derivatives" |
| | WO-07058626A1 (PCT ansøgning) |
| | "Indazole compounds" |
| | Yderligere 2 provisional patent ansøgninger indsendt |
| | |
| Publikationer | J. Biomol. Screen., 11 (2006), 959-967 |
| | "Sirt1 Modulating Compounds from High-Throughput Screening as Anti-Inflammatory and Insulin Sensitizing Agents" |
| | J. Comput.-Aided Mol. Design, 17 (2003), 765-783 |
| | "Pharmacophore and receptor models for Neurokinin receptors" |
| | J. Comput.-Aided Mol. Design, 16 (2002), 273-286 |
| | "A pharmacophore model for Neurokinin 2 antagonists comprising compounds from several structurally diverse classes" |
| | Tetrahedron 55 (1999) 1427-1440 |
| | "Combining the [2,3] Sigmatropic Rearrangement and Ring-Closing Metathesis Strategies for the Synthesis of Spirocyclic Alkaloids. A Short and Efficient Route to (±)-Perhydrohistrionicotoxin" |
| | |
| Konferencer | CHI Structure-Based Design , Boston, USA,June 6-8, 2007 |
| | Poster: A Web-based Docking Interface for theBench Chemist. |
| | Schrodinger Spring Symposium , New York, USA,15-17. April, 2007 |
| | Foredrag: A Web-based Glide Docking Interface for theBench Chemist. |
| | Modern Trends in Healthcare , Singapore,27. Marts, 2007 |
| | Foredrag: Virtual Screening. |
| | The 16th European Symposium on QSAR and Molecular Modelling, Italy, 10-17. September, 2006 |
| | Poster: A Web-based Docking Interface for the Bench Chemist. |
| | Catalyst User Group Meeting, Philadelphia, USA, 13. Oktober, 2003 |
| Foredrag: An evaluation of Catalyst's conformational search algorithm with regard to conformational diversity and conformational energy penalties. |
| Catalyst User Group Meeting, Copenhagen, Denmark, 9. Oktober, 2002 |
| Foredrag: An evaluation of Catalyst's conformational search algorithm with regard to conformational diversity and conformational energy penalties. |
| MGMS meeting on Structure-Based Drug Design, 13-15. December, 2000 in Oxford, England |
| | Poster: A pharmacophore model for Neurokinin 2 antagonists based on compounds from several diverse structural classes. |
| | |
| Opdateret | Singapore, 3. juli, 2007. |
